Metaanalyse
Meta-Analysis: Cardiovascular Risks Rose After Stopping Aspirin
JAMA · 2024
DOI: 10.1001/jama.2024.2091 ↗Kurz gefasst
Metaanalyse in der Zeitschrift JAMA, 2024. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Aspirin, Cardiovascular Diseases, Platelet Aggregation Inhibitors, Withholding Treatment.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AspirinCardiovascular DiseasesPlatelet Aggregation InhibitorsWithholding TreatmentHumansHeart Disease Risk FactorsPrimary PreventionRisk FactorsMeta-Analysis as Topic
Substanzen
AspirinPlatelet Aggregation Inhibitors
Zitieren
APA
Harris, E. (2024). Meta-Analysis: Cardiovascular Risks Rose After Stopping Aspirin. JAMA. https://doi.org/10.1001/jama.2024.2091
Vancouver
Harris E. Meta-Analysis: Cardiovascular Risks Rose After Stopping Aspirin. JAMA. 2024. doi:10.1001/jama.2024.2091
BibTeX
@article{Harris2024,
author = {Harris, Emily},
title = {Meta-Analysis: Cardiovascular Risks Rose After Stopping Aspirin},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.2091}
}
EUVIMED